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Ethnicity	 Not	reported	 Not	reported	 90%	British	Caucasian	 Not	reported	 Not	reported	
100%	British	
Caucasian	 Not	reported	 Not	reported	 Not	reported	 97%	Caucasian	
Number	of	
participants	(%	F)	 16	(80%)	 150	(80%)	 40	(55%)	 24	(100%)	 24	(46%)	 50	(92%)	 90	(71%)	 139	(65%)	 75	(100%)	 67	(78%)	
Mean	age	(SD)	 49.8	(6.8)	 47.3	(10.3)	 52.2	(9.1)	 NR	 32.3	(5.1)	 45	(10.9)	 44.6	(9.4)	 42.7	(8.7)	 37.5	(6.5)	 52.94	(11.37)	
Socio-economic	






















































































EDSS	score	 Not	reported	 Mean	(SD)	3.0	(1.1)	 Mean	(SD)	6.5	(1.5)	 Not	reported	 Not	reported	 4.4	(1.8)	 2.3	(1.7)	 Median	3.0	 Not	reported	 4.6	(1.93)	








On	DMDs	 Not	reported	 91	(60.1%)	 Not	reported	 Not	reported	 Not	reported	 26	(52%)	 Not	reported	 104	(85%)	 Not	reported	 34	(55%)	
Psychotropic	
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movement	
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Figure	6	Risk	of	Bias	Forest	plot	for	fatigue	studies
	
TE	-	Treatment	effect;	seTE	-	standard	error	of	the	TE;	SMD	–	Standardised	mean	difference;	95%CI	-	95%	confidence	
interval;	Weight	-	weight	contributed	by	each	study	
	
		
3.5	Adverse	events	
Two	studies	reported	on	adverse	events	associated	with	MBI	exposure	32	34.	In	
one	study	that	used	MBSR	a	participant	reported	an	episode	of	increased	
spasticity	during	mindful	body	awareness	34.	In	the	same	study	another	
participant	described	increased	anxiety	following	the	MBSR	retreat	34.	In	another	
study	using	MBSR	one	participant	with	chronic	pain	reported	increased	
symptoms	following	the	raisin	exercise	32.		
	
4.1	Discussion	
4.2	Summary	of	main	findings	
Ten	RCTs	that	assessed	the	effects	of	an	MBI	on	physical	symptom	outcomes	in	
PwMS	were	eligible	for	inclusion	in	our	systematic	review;	seven	of	these	had	
data	extractable	for	use	in	our	meta-analysis.	Four	studies	tested	an	MBI	against	
an	active	comparator,	four	tested	against	treatment	as	usual,	whilst	the	control	
condition	was	unclear	in	the	remaining	two	studies.	Intervention	fidelity	was	
reliably	assessed	in	only	one	study.	Sample	sizes	were	frequently	small.	Follow-
ups	took	place	from	immediately	post-MBI	to	up	to	1	year	following	course	
completion.		
	
Six	hundred	and	seventy-eight	PwMS	were	included	in	these	studies.	Most	(58%)	
had	relapsing	phenotypes.	Most	participants	were	female;	mostly	of	Caucasian	
ethnicity.	In	general,	comorbidity	and	disability	levels	were	poorly	reported.		
	
Four	studies	used	MBSR,	two	were	loosely	modeled	on	MBSR;	two	explicitly	used	
MBCT,	one	‘Mindfulness	of	Movement’,	and	in	one	case	the	basis	for	the	MBI	was	
unclear.	Most	interventions	were	provided	as	groups	(n=5-25),	delivering	core	
MBI	practices	in	and	between	sessions.	Level	of	teacher	training	and	experience	
were	not	well	reported.	MBI	session	attendance	+/-	home	practice	(treatment	
adherence)	was	described	in	six	studies.	Rates	of	attrition	varied	considerably	
(0-39%).	Although	very	few	adverse	events	were	described	from	MBI	training,	
few	studies	explicitly	reported	on	this	outcome.	
	
Five	RCTs	were	categorised	as	overall	low	RoB	using	the	Cochrane	Collaboration	
tool,	three	as	high	and	two	as	unclear,	signifying	an	overall	improvement	in	
study	quality	since	we	last	assessed	this	in	2014	14.			
	
Our	meta-analysis	indicates	that	MBIs	are	modestly	effective	treatments	for	
fatigue	in	PwMS,	but	evidence	to	support	improvements	in	pain	is	inconsistent.	
No	MBI	is	clearly	optimal	for	treating	impairment	of	fatigue	in	PwMS.	
	
4.3	Comparison	with	existing	literature	
In	this	study	we	found	MBIs	moderately	effective	for	improving	fatigue	(SMD	
0.24;	0.08	–	0.41),	but	inconsistent	with	regards	to	effects	on	pain	(SMD	0.16;	-
0.46	–	0.79)	in	PwMS.		
	
A	2018	meta-analysis	36	of	psychological	interventions	for	treating	fatigue	in	
PwMS	reported	CBT	to	be	moderately	effective	(SMD	0.32;	0.01	–	0.63)	and	MBIs	
to	be	considerably	more	effective	(SMD	0.62;	0.12	–	1.12),	but	only	included	two	
30	35	of	the	seven	26	28	30	32-35	RCTs	identified	in	our	current	review,	likely	
reflecting	an	earlier	search	cut-off	date	in	their	study	(April	2017).		
	
No	previous	meta-analysis	has	assessed	the	impact	of	MBI	training	on	pain	in	
PwMS,	but	in	chronic	pain	populations	at	large,	several	meta-analyses	have	been	
conducted.	A	2014	meta-analysis	37	reported	moderate	overall	treatment	effects	
(Cohen’s	d)	from	MBI	training	(0.33;	0.03	–	0.62),	a	finding	that	diminished	to	a	
null	effect	when	examining	the	effect	against	active	comparators.	A	2015	meta-
analysis	38	comprising	painful	musculoskeletal	conditions	reported	small	effects	
(Hedge’s	g)	versus	usual	care	following	MBI	training	on	pain	intensity	(0.16;	0.03	
–	0.36;	the	effect	attenuated	when	compared	against	active	comparators	to	0.09;	
-0.13	–	0.31),	moderate	effects	on	perceived	pain	control	(0.58;	0.23	–	0.93),	but	
larger	effects	on	pain	acceptance	versus	usual	care	(1.58;	-0.57	–	3.74).	Finally,	a	
2017	meta-analysis	39	found	small	overall	effects	against	any	comparator,	SMD	
0.32	(0.09	–	0.54),	but	included	a	wide	variety	of	clinical	syndromes.	
	
4.4	Strengths	of	this	review	
Guided	by	the	PRISMA	checklist	20,	the	TIDieR	checklist	18	and	the	Cochrane	
Collaboration	tool	19,	our	multidisciplinary	team	of	experienced	reviewers	used	
robust	search,	appraisal	and	analysis	techniques	for	extracting	and	analysing	
data	in	this	systematic	review	and	meta-analysis.	
	
4.5	Limitations	of	this	review	
Although	we	assessed	quality	using	a	reference	standard,	the	Cochrane	
Collaboration	RoB	tool,	we	did	not	estimate	the	strength	of	any	recommendation	
for	use	of	MBIs	in	PwMS.	Future	studies	could	do	so	by	applying	the	GRADE	
criteria	40.	
	
Meta-analyses	of	RCTs	by	design	exclude	other	potentially	relevant	data,	such	as	
that	deriving	from	observational	or	qualitative	research.	When	considering	
intervention	feasibility,	such	as	acceptability,	accessibility	and	implementability,	
these	alternate	study	designs	can	provide	important	insights	into	how	and	why	
interventions	succeed	or	fail	in	a	given	context.	However,	in	this	current	study,	
the	use	of	SPIO,	the	TIDieR	checklist	and	Cochrane	Collaboration	tool	for	RoB,	
means	that	our	evidence	synthesis	has	covered	other,	related	aspects	of	trial	
feasibility	and	execution.		
	
4.6	Strengths	and	Limitations	of	the	included	studies	
When	considering	the	strength	of	evidence	for	the	use	of	MBIs	in	PwMS,	most	
studies	which	assessed	impact	on	fatigue	(n=5/7)	and	all	that	assessed	impact	
on	pain	(n=3)	were	adjudged	low	RoB.	However,	despite	all	studies	being	RCTs,	
participant	numbers	were	low	(n=<50)	in	four.	Although	all	MS	phenotypes	were	
represented,	most	participants	had	relapsing-remitting	MS.	Furthermore,	mean	
sample	age	was	relatively	low	(46.0),	whilst	ethnicity,	SES	and	comorbidity	were	
poorly	covered,	limiting	the	generalisability	of	findings.	To	complicate	matters,	
several	studies	tailored	their	MBIs	with	minimal/absent	prior	justification.	Only	
four	compared	an	MBI	against	an	active	comparator	condition.	Observed	effects	
were	mostly	small,	with	a	wide	range	of	confidence	intervals.	Heterogeneity,	
overall,	was	low.		
	
Given	the	well	documented	high	levels	of	physical	comorbidity	in	PwMS,	it	is	
notable	that	our	meta-analysis	has	only	been	able	to	quantify	the	effects	of	MBI	
training	on	two,	albeit	common,	facets	of	physical	wellbeing,	namely	fatigue	and	
pain.	Other	aspects	of	physical	wellbeing	were	measured	in	individual	studies	
(e.g.	standing	balance,	sleep	and	sexual	function),	where	beneficial	effects	were	
reported,	but	meta-analysis	was	not	possible.	Future	studies	could	address	this	
evidence	gap	by	measuring	the	impact	of	MBI	training	on	other	common	physical	
symptoms	associated	with	MS,	for	example	dysarthria,	dysphagia,	bowel	and	
bladder	dysfunction,	dynamic	balance,	in-coordination	and	spasticity.	Although	
MBSR	and	MBCT	both	appear	to	be	effective	treatments	for	fatigue,	it	is	not	
currently	possible	to	recommend	one	approach	over	the	other.		
	
4.7	Implications	for	research	
The	quality	of	evidence	for	MBIs	as	effective	treatments	for	fatigue	in	PwMS	has	
improved	considerably	since	our	systematic	review	in	2014.	However,	
adherence	to	CONSORT	17	reporting	was	poor	in	several	studies	included	in	the	
meta-analysis,	with	three	studies	assessed	overall	as	high	risk	and	two	as	
unclear	according	to	the	Cochrane	Collaboration	19	tool.	In	addition,	MBI	
description	was	often	sparse	in	detail.	Were	researchers	to	adhere	more	closely	
to	the	CONSORT	17	and	TIDieR	18	checklists	when	reporting	studies	of	MBIs	for	
PwMS,	the	knowledge	base	in	this	area	could	be	further	enhanced,	helping	to	
clarify	where	further	research	efforts	should	focus.	
	
It	remains	unclear	which	type	of	MBI	may	be	best	for	PwMS	with	impaired	
physical	wellbeing	in	general,	or	fatigue	or	pain	more	specifically.	Future	
research	could	test	either	MBSR	or	MBCT	against	established	treatments	in	this	
area;	by	involving	people	affected	with	the	condition	in	this	endeavor,	the	co-
design,	delivery	and	ongoing	development	of	an	optimised	MBI	course	for	PwMS	
could	take	place	8.		
	
4.8	Implications	for	clinical	practice	
MBIs	appear	to	be	modestly	effective	at	improving	fatigue	in	PwMS.		
	
5.1	Conclusions	
Meta-analytic	evidence	supports	the	use	of	MBIs	in	PwMS	to	improve	fatigue.	
Evidence	to	support	the	use	of	MBIs	for	treating	pain	in	this	population	is	
inconsistent.	Although	the	quality	of	study	reporting	has	become	better,	room	
still	exists	for	enhanced	reporting	in	this	area.	No	clear	optimal	MBI	exists	for	
improving	impaired	physical	wellbeing	in	PwMS.		
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